Skip to main content
TipRanks
Go Ultimate75% OFF

Prelude Therapeutics (PRLD) Q3 2026 Earnings Report

196 Followers

PRLD Q3 2026 EPS Results

Actual EPS
―
Consensus EPS
$0.01
Beat/Miss
―
One Year Ago EPS
-$0.26

PRLD Q3 2026 Revenue Results

Actual Revenue
―
Expected Revenue
$29.00M
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q3 2026
Date
11/05/2026
Time
TBA
Conference Call
Thursday, November 5, 2026
PRLD Upcoming Earnings

Prelude Therapeutics's next earnings date is estimated for March 16, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

PRLD Earnings History

PRLD earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 16, 20272026 (Q4)―--0.2――
Nov 05, 20262026 (Q3)0.01--0.26―
Aug 19, 20262026 (Q2)-0.20-0.14-0.4165.85% (+0.27)
May 12, 20262026 (Q1)-0.25-0.13-0.4269.05% (+0.29)
Mar 10, 20262025 (Q4)-0.03-0.20-0.3745.95% (+0.17)
Nov 12, 20252025 (Q3)-0.37-0.26-0.4339.53% (+0.17)
Aug 14, 20252025 (Q2)-0.44-0.41-0.4610.87% (+0.05)
May 06, 20252025 (Q1)-0.47-0.42-0.420.00% (+0.00)
Mar 10, 20252024 (Q4)-0.46-0.37-0.4517.78% (+0.08)
Nov 06, 20242024 (Q3)-0.47-0.43-0.454.44% (+0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed